Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma

Glioblastoma (GBM) is the most aggressive brain tumor of the central nervous system. Recent studies have reported the crucial functions of Tripartite Motif Containing 24 (TRIM24) in promoting cancer progression of GBM. However, it remains unclear if TRIM24 is an attractive druggable target for thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Mingzhi, Sun, Yanfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662887/
https://www.ncbi.nlm.nih.gov/pubmed/34886858
http://dx.doi.org/10.1186/s12967-021-03158-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662887/
https://www.ncbi.nlm.nih.gov/pubmed/34886858
http://dx.doi.org/10.1186/s12967-021-03158-w

Ejemplares similares